Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SToP Trial for skin infections in Kimberley Aboriginal communities
ACTRN12618000520235Phase 4Completed
- Sponsor
- Kids Research Institute Australia
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of trimethoprim + sulfamethoxazole and ivermectin in impetigo, scabies and crusted scabies (CS) (3 arms), sponsored by Kids Research Institute Australia. Primary endpoint: Primary: diagnosis of impetigo in children aged 5 to less than 10 years. Started Sep 2018; status: completed.
02
Drugs
trimethoprim + sulfamethoxazoleivermectin
03
Conditions
impetigoscabiescrusted scabies (CS)
Beyond the preview
Go deeper on ACTRN12618000520235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000520235.